Breakdown | TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 18.51B | 18.71B | 15.91B | 10.30B | 7.09B | 3.69B |
Gross Profit | 6.72B | 6.05B | 3.91B | 2.77B | 2.02B | 1.62B |
EBITDA | 2.55B | 2.06B | 1.54B | 1.11B | 893.28M | 658.83M |
Net Income | 1.50B | 1.01B | 746.43M | 472.52M | 411.38M | 291.86M |
Balance Sheet | ||||||
Total Assets | 12.47B | 14.21B | 9.26B | 6.64B | 7.14B | 6.12B |
Cash, Cash Equivalents and Short-Term Investments | 4.12B | 5.07B | 4.02B | 2.52B | 3.43B | 2.95B |
Total Debt | 2.00B | 2.00B | 1.50B | 646.00K | 6.94M | 15.10M |
Total Liabilities | 6.56B | 8.32B | 4.15B | 1.97B | 2.76B | 2.11B |
Stockholders Equity | 5.65B | 5.63B | 4.91B | 4.50B | 4.22B | 3.82B |
Cash Flow | ||||||
Free Cash Flow | 1.15B | 1.14B | 366.07M | -719.20M | 488.44M | -858.85M |
Operating Cash Flow | 1.16B | 1.71B | 865.91M | -212.18M | 957.08M | -537.31M |
Investing Cash Flow | -543.24M | -719.17M | -529.93M | -531.21M | -465.67M | -336.75M |
Financing Cash Flow | -1.13B | 63.81M | 1.28B | -303.04M | -3.81M | 684.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥27.50B | 6.58 | 2.16% | 19.63% | 23.87% | ||
68 Neutral | ¥2.26B | 5.22 | 5.29% | 12.55% | ― | ||
67 Neutral | ¥43.87B | 29.67 | 1.18% | 3.46% | 62.65% | ||
59 Neutral | ¥3.41B | 12.36 | 2.63% | 47.88% | -21.61% | ||
50 Neutral | AU$1.47B | 2.06 | -28.25% | 3.11% | 16.21% | -7.40% |
GMO Financial Gate, Inc. has announced its transition from the Tokyo Stock Exchange Growth Market to the Tokyo Stock Exchange Prime Market. This move signifies a strategic step in the company’s growth trajectory, aiming to boost business performance and corporate value, while reinforcing its commitment to stakeholders.
The most recent analyst rating on (JP:4051) stock is a Buy with a Yen10200.00 price target. To see the full list of analyst forecasts on GMO Financial Gate, Inc. stock, see the JP:4051 Stock Forecast page.
GMO Financial Gate, Inc. announced its approval to move its stock listing from the Growth Market to the Prime Market of the Tokyo Stock Exchange, effective June 5, 2025. This transition is expected to accelerate the company’s growth, strengthen corporate governance, and enhance information disclosure, thereby increasing corporate value and meeting stakeholder expectations.
The most recent analyst rating on (JP:4051) stock is a Buy with a Yen10200.00 price target. To see the full list of analyst forecasts on GMO Financial Gate, Inc. stock, see the JP:4051 Stock Forecast page.
GMO Financial Gate, Inc. reported lower initial revenues for Q2 FY2025 due to a downward trend in the SME sector, but recurring revenue has contributed positively to operating profit. The company aims to expand its total addressable market by broadening its business domain, which could enhance its industry positioning and potentially benefit stakeholders.
The most recent analyst rating on (JP:4051) stock is a Buy with a Yen10200.00 price target. To see the full list of analyst forecasts on GMO Financial Gate, Inc. stock, see the JP:4051 Stock Forecast page.
GMO Financial Gate, Inc. reported its consolidated financial results for the second quarter of FY2025, showing a slight decrease in revenue by 2.1% year-on-year. However, the company experienced significant growth in operating profit and profit attributable to owners of the parent, with increases of 48.5% and 66.4% respectively. The financial forecast for the full fiscal year 2025 indicates a positive outlook with expected revenue growth of 18.7% and a substantial increase in profits. This performance underscores the company’s strong market position and operational efficiency, which are likely to benefit stakeholders.
The most recent analyst rating on (JP:4051) stock is a Buy with a Yen10200.00 price target. To see the full list of analyst forecasts on GMO Financial Gate, Inc. stock, see the JP:4051 Stock Forecast page.